These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6861042)

  • 21. Tumor associated antigen (TAA) mimicry and immunotherapy of malignant diseases from anti-idiotypic antibodies to peptide mimics.
    Wang X; Luo W; Foon KA; Ferrone S
    Cancer Chemother Biol Response Modif; 2001; 19():309-26. PubMed ID: 11686020
    [No Abstract]   [Full Text] [Related]  

  • 22. [Laboratory tests in the diagnosis of cancer. Biological markers of cancer].
    Senra Varela A; Palmeiro Troitiño R; Millán Núñez-Cortés J; García-Blanco Saceda P
    Rev Clin Esp; 1982 Jul 15-31; 166(1-2):1-6. PubMed ID: 7146512
    [No Abstract]   [Full Text] [Related]  

  • 23. Tumour immunity.
    Aikat BK
    Indian J Pathol Bacteriol; 1974 Apr; 17(2):69-74. PubMed ID: 4455621
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunotherapy for colorectal cancer.
    Midgley RS; Kerr DJ
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):63-78. PubMed ID: 12597351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early detection of cancers by serum and histological diagnosis using monoclonal antibodies].
    Kannagi R; Itai S; Harada R; Hashimoto K; Oka Y
    Nihon Rinsho; 1989 May; 47(5):1079-94. PubMed ID: 2746902
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N; Zoernig I; Jäger D
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens.
    Kuroki M; Shibaguchi H; Imakiire T; Uno K; Shirota K; Higuchi T; Shitama T; Yamada H; Hirose Y; Nagata A; Kuroki M
    Anticancer Res; 2003; 23(6a):4377-81. PubMed ID: 14666724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer immunotherapy: a treatment for the masses.
    Blattman JN; Greenberg PD
    Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy of prostate cancer.
    Doehn C
    Eur Urol; 2008 Apr; 53(4):681-3; discussion 684-5. PubMed ID: 18248878
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunotherapy for infection and malignancy in children with cancer.
    Frost JD; Sondel PM
    Adv Pediatr; 1994; 41():385-413. PubMed ID: 7992692
    [No Abstract]   [Full Text] [Related]  

  • 31. Recombinant bispecific antibodies for cellular cancer immunotherapy.
    Müller D; Kontermann RE
    Curr Opin Mol Ther; 2007 Aug; 9(4):319-26. PubMed ID: 17694444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Monoclonal antibodies in oncology, a new hope for an unsolved problem].
    Colnaghi MI; Farante GE; Canevari S; Salvadori B; Ménard S
    Medicina (B Aires); 1987; 47(6):667-72. PubMed ID: 3333079
    [No Abstract]   [Full Text] [Related]  

  • 33. Monoclonal antibody therapy for solid tumors.
    Green MC; Murray JL; Hortobagyi GN
    Cancer Treat Rev; 2000 Aug; 26(4):269-86. PubMed ID: 10913382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
    Jäger D; Jäger E; Bert F; Knuth A
    Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
    [No Abstract]   [Full Text] [Related]  

  • 35. Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.
    Ribas A; Camacho LH; Lopez-Berestein G; Pavlov D; Bulanhagui CA; Millham R; Comin-Anduix B; Reuben JM; Seja E; Parker CA; Sharma A; Glaspy JA; Gomez-Navarro J
    J Clin Oncol; 2005 Dec; 23(35):8968-77. PubMed ID: 16204013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological diagnosis of cancer.
    Neville AM
    BTTA Rev; 1972 Jun; 2(2):37. PubMed ID: 5035110
    [No Abstract]   [Full Text] [Related]  

  • 37. Engineering mouse monoclonal antibodies for cancer immunotherapy.
    Orlandi R
    Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
    [No Abstract]   [Full Text] [Related]  

  • 38. [Telomerase, a universal target in immunotherapy strategies against tumor?].
    Rousseau R; Soria JC
    Bull Cancer; 2000 Dec; 87(12):895-901. PubMed ID: 11174119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemically detecting target antigens in patient biopsies for tailoring monoclonal antibody based cancer therapy.
    Smith NL; Finley JL; Wennerberg AE; Semer DA; Kearse KP
    Hum Antibodies; 1999; 9(1):61-5. PubMed ID: 10331187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A streptococcal preparation (OK-432) enhances monoclonal antibody NCC-ST-421 cytotoxicity against human colon cancer.
    Kawano Y; Watanabe M; Kubota T; Nishibori H; Kurihara N; Teramoto T; Kitajima M
    Anticancer Res; 1997; 17(4A):2449-53. PubMed ID: 9252661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.